AAM
ALXN

Azzad Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,815
Closed -$909K 321
2020
Q4
$909K Buy
5,815
+29
+0.5% +$4.53K 0.16% 200
2020
Q3
$662K Buy
5,786
+912
+19% +$104K 0.14% 214
2020
Q2
$547K Buy
+4,874
New +$547K 0.13% 228
2020
Q1
Sell
-7,123
Closed -$790K 358
2019
Q4
$790K Sell
7,123
-36
-0.5% -$3.99K 0.09% 267
2019
Q3
$771K Buy
7,159
+4,877
+214% +$525K 0.1% 265
2019
Q2
$299K Sell
2,282
-30
-1% -$3.93K 0.08% 270
2019
Q1
$313K Sell
2,312
-3
-0.1% -$406 0.09% 260
2018
Q4
$225K Sell
2,315
-194
-8% -$18.9K 0.08% 288
2018
Q3
$349K Sell
2,509
-64
-2% -$8.9K 0.09% 284
2018
Q2
$319K Buy
2,573
+47
+2% +$5.83K 0.09% 280
2018
Q1
$282K Buy
2,526
+53
+2% +$5.91K 0.09% 278
2017
Q4
$296K Buy
2,473
+95
+4% +$11.4K 0.09% 260
2017
Q3
$334K Buy
2,378
+85
+4% +$11.9K 0.11% 251
2017
Q2
$279K Sell
2,293
-5,921
-72% -$720K 0.1% 269
2017
Q1
$996K Buy
8,214
+161
+2% +$19.5K 0.38% 102
2016
Q4
$985K Buy
8,053
+47
+0.6% +$5.75K 0.41% 85
2016
Q3
$981K Sell
8,006
-38
-0.5% -$4.66K 0.4% 94
2016
Q2
$939K Buy
8,044
+1,367
+20% +$160K 0.4% 90
2016
Q1
$930K Buy
6,677
+106
+2% +$14.8K 0.41% 94
2015
Q4
$1.25M Buy
6,571
+40
+0.6% +$7.63K 0.6% 43
2015
Q3
$1.02M Buy
6,531
+86
+1% +$13.4K 0.54% 62
2015
Q2
$1.17M Sell
6,445
-18
-0.3% -$3.25K 0.59% 49
2015
Q1
$1.12M Buy
6,463
+38
+0.6% +$6.59K 0.54% 50
2014
Q4
$1.19M Buy
6,425
+91
+1% +$16.8K 0.63% 33
2014
Q3
$1.05M Buy
6,334
+73
+1% +$12.1K 0.61% 33
2014
Q2
$978K Buy
6,261
+8
+0.1% +$1.25K 0.59% 38
2014
Q1
$938K Buy
6,253
+101
+2% +$15.2K 0.62% 29
2013
Q4
$817K Buy
6,152
+119
+2% +$15.8K 0.59% 42
2013
Q3
$701K Hold
6,033
0.58% 49
2013
Q2
$587K Buy
+6,033
New +$587K 0.5% 61